ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 108 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $419,000 | +6.9% | 286,957 | +3.9% | 0.00% | 0.0% |
| Q4 2016 | $392,000 | -13.3% | 276,171 | +7.0% | 0.00% | 0.0% |
| Q3 2016 | $452,000 | +4.4% | 258,089 | +1.9% | 0.00% | 0.0% |
| Q2 2016 | $433,000 | -11.6% | 253,279 | +1.9% | 0.00% | -50.0% |
| Q1 2016 | $490,000 | +4.3% | 248,649 | +0.5% | 0.00% | 0.0% |
| Q4 2015 | $470,000 | +8.8% | 247,399 | +9.3% | 0.00% | +100.0% |
| Q3 2015 | $432,000 | -59.2% | 226,424 | -0.8% | 0.00% | -66.7% |
| Q2 2015 | $1,059,000 | -3.1% | 228,251 | -8.8% | 0.00% | 0.0% |
| Q1 2015 | $1,093,000 | +58.4% | 250,151 | +25.7% | 0.00% | +50.0% |
| Q4 2014 | $690,000 | -19.3% | 198,951 | -2.5% | 0.00% | -33.3% |
| Q3 2014 | $855,000 | -28.6% | 204,137 | -0.0% | 0.00% | -25.0% |
| Q2 2014 | $1,197,000 | -13.3% | 204,237 | -6.8% | 0.00% | 0.0% |
| Q1 2014 | $1,381,000 | +4.9% | 219,249 | -2.5% | 0.00% | 0.0% |
| Q4 2013 | $1,316,000 | +4.9% | 224,969 | -5.5% | 0.00% | 0.0% |
| Q3 2013 | $1,255,000 | -32.1% | 238,099 | -0.8% | 0.00% | -33.3% |
| Q2 2013 | $1,849,000 | – | 240,085 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |